News

Filter

Current filters:

Cardio-vascular

51 to 60 of 97538 results

AstraZeneca files marketing authorization application with EMA for lesinurad

AstraZeneca files marketing authorization application with EMA for lesinurad

22-01-2015

The European Medicines Agency has accepted the marketing authorization application by AstraZeneca for…

AstraZenecaGastro-intestinalslesinuradPharmaceuticalRegulation

BIO responds to President Obama's State of the Union speech

22-01-2015

In his State of the Union speech to the American public this week, US President Barak Obama said that…

BiotechnologyPoliticsResearchUSA

Ablynx successfully opposes Domantis' European patent appeal

Ablynx successfully opposes Domantis' European patent appeal

22-01-2015

Belgian drug developer Ablynx has successfully opposed the appeal lodged by Domantis over its European…

AblynxEuropeGSKLegalPharmaceutical

Syncona and UCL Business form cancer immunotherapy company Autolus

Syncona and UCL Business form cancer immunotherapy company Autolus

22-01-2015

Investment company Syncona and UCL Business, the wholly-owned technology transfer company of University…

BiologyBiotechnologyOncologyResearchUK

Latest approval for Novartis’ Cosentyx, from US FDA

Latest approval for Novartis’ Cosentyx, from US FDA

22-01-2015

Adding to recent marketing clearances in Japan and the European Union, the US Food and Drug Administration…

BiotechnologyCosentyxDermatologicalsNovartisRegulationUSA

Repligen appoints Tony Hunt as chief executive officer

Repligen appoints Tony Hunt as chief executive officer

21-01-2015

Biologics specialist Repligen has appointed Tony Hunt as the company’s next chief executive officer.

BiosimilarsBoardroomLife TechnologiesRepligenTony Hunt

EastGate Biotech Corp appoints Rose Perri as president

EastGate Biotech Corp appoints Rose Perri as president

21-01-2015

Drug delivery and dosage specialist EastGate Biotech Corp has appointed Rose Perri as president.

BiotechnologyBoardroomEastGate Biotech CorpPresidentRose Perri

US and EU regulatory filings for UCB’s antiepileptic brivaracetam

US and EU regulatory filings for UCB’s antiepileptic brivaracetam

21-01-2015

Belgium’s largest pharma company UCB today announced regulatory filings in the USA and the European…

BRIVARACETAMEuropeNeurologicalPharmaceuticalRegulationUCBUSA

51 to 60 of 97538 results

Back to top